ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Trading 0.6% Higher – Here’s What Happened

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)’s stock price traded up 0.6% during trading on Thursday . The stock traded as high as $51.69 and last traded at $51.09. 65,323 shares traded hands during trading, an increase of 218% from the average session volume of 20,543 shares. The stock had previously closed at $50.81.

ALPS Medical Breakthroughs ETF Trading Up 0.3%

The stock’s fifty day simple moving average is $45.56 and its two-hundred day simple moving average is $37.64.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Comerica Bank bought a new stake in shares of ALPS Medical Breakthroughs ETF in the 3rd quarter valued at about $27,000. Strategic Financial Services Inc. lifted its stake in shares of ALPS Medical Breakthroughs ETF by 12.7% in the first quarter. Strategic Financial Services Inc. now owns 19,225 shares of the company’s stock worth $548,000 after acquiring an additional 2,163 shares during the period. Raymond James Financial Inc. acquired a new position in shares of ALPS Medical Breakthroughs ETF in the second quarter worth approximately $82,000. Ally Invest Advisors Inc. bought a new stake in ALPS Medical Breakthroughs ETF in the second quarter valued at approximately $200,000. Finally, Moran Wealth Management LLC increased its position in ALPS Medical Breakthroughs ETF by 72.2% during the 3rd quarter. Moran Wealth Management LLC now owns 17,187 shares of the company’s stock valued at $668,000 after purchasing an additional 7,206 shares during the period.

About ALPS Medical Breakthroughs ETF

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.